BMEA
Price
$1.22
Change
+$0.08 (+7.02%)
Updated
Feb 6 closing price
Capitalization
86.26M
56 days until earnings call
Intraday BUY SELL Signals
NTLA
Price
$12.28
Change
+$1.19 (+10.73%)
Updated
Feb 6 closing price
Capitalization
1.42B
10 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMEA vs NTLA

Header iconBMEA vs NTLA Comparison
Open Charts BMEA vs NTLABanner chart's image
Biomea Fusion
Price$1.22
Change+$0.08 (+7.02%)
Volume$1.19M
Capitalization86.26M
Intellia Therapeutics
Price$12.28
Change+$1.19 (+10.73%)
Volume$4.61M
Capitalization1.42B
BMEA vs NTLA Comparison Chart in %
View a ticker or compare two or three
VS
BMEA vs. NTLA commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (BMEA: $1.22 vs. NTLA: $12.28)
Brand notoriety: BMEA and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 85% vs. NTLA: 91%
Market capitalization -- BMEA: $86.26M vs. NTLA: $1.42B
BMEA [@Biotechnology] is valued at $86.26M. NTLA’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than BMEA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 2 TA indicator(s) are bullish while NTLA’s TA Score has 6 bullish TA indicator(s).

  • BMEA’s TA Score: 2 bullish, 7 bearish.
  • NTLA’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than BMEA.

Price Growth

BMEA (@Biotechnology) experienced а +8.93% price change this week, while NTLA (@Biotechnology) price change was -6.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

BMEA is expected to report earnings on Apr 06, 2026.

NTLA is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.42B) has a higher market cap than BMEA($86.3M). NTLA YTD gains are higher at: 36.596 vs. BMEA (-1.613). BMEA has higher annual earnings (EBITDA): -97.83M vs. NTLA (-466.25M). NTLA has more cash in the bank: 511M vs. BMEA (46.6M). BMEA has less debt than NTLA: BMEA (6.88M) vs NTLA (98M). NTLA has higher revenues than BMEA: NTLA (57.5M) vs BMEA (0).
BMEANTLABMEA / NTLA
Capitalization86.3M1.42B6%
EBITDA-97.83M-466.25M21%
Gain YTD-1.61336.596-4%
P/E RatioN/AN/A-
Revenue057.5M-
Total Cash46.6M511M9%
Total Debt6.88M98M7%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEANTLA
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signal:
Gain/Loss:
NTLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OGICX41.861.06
+2.60%
Invesco Global Opportunities C
FZAEX47.310.90
+1.94%
Fidelity Advisor Focused Em Mkts Z
EIPTX13.770.26
+1.92%
UBS Engage For Impact P2
ALBCX93.351.73
+1.89%
Alger Growth & Income C
GVIYX13.640.22
+1.64%
GuideStone Funds Value Equity Idx Instl

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with TCRX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+7.02%
TCRX - BMEA
50%
Loosely correlated
+13.14%
BDTX - BMEA
47%
Loosely correlated
+4.40%
NTLA - BMEA
46%
Loosely correlated
+10.73%
ARCT - BMEA
46%
Loosely correlated
+7.83%
VTGN - BMEA
45%
Loosely correlated
+11.52%
More